Evaluation of the Efficacy and Safety of Zinc in Viral Infections

NACompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

May 4, 2022

Study Completion Date

May 4, 2022

Conditions
SARS-CoV2 Infection
Interventions
DIETARY_SUPPLEMENT

Zinc

For each patient included, a prescription regimen of zinc (in bisglycinate form) is proposed at a dose of 25 mgtwice a day for 15 days for the intervention arm. This dose of zinc is to be taken away from meals.

DIETARY_SUPPLEMENT

Placebo

For each patient included, a prescription of an identical to the intervention arm concerning shape, smell, taste and color pill of placebo . This dose of zinc is to be taken away from meals.

Trial Locations (1)

5000

EPS Fattouma Bourguiba Monastir, Monastir

All Listed Sponsors
lead

University of Monastir

OTHER